We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

AI in Pharma – Adoption, Disruption and Drug Discovery

Article   Feb 04, 2020 | By Laura Elizabeth Lansdowne, Senior Science Writer, Technology Networks

 
AI in Pharma – Adoption, Disruption and Drug Discovery

Laura Elizabeth Lansdowne

Senior Science Writer

 
 
 

RELATED ARTICLES

HPC-powered Solutions Offer a Widescreen Approach to Scientific Visualization

Article

A new system named “Hopcroft” has brought advanced new data generation and processing capabilities to researchers and artists at Northern Illinois University. In this article, we discover how high-performance computing (HPC) has helped power-up "Hopcroft".

READ MORE

How Technology Is Transforming Healthcare for Mesothelioma Patients

Article

Three dimensional (3D) bioprinting and artificial intelligence (AI) have been fundamental technologies for understanding disease and contributing to groundbreaking research. Within the past year, technological developments have provided opportunities for early diagnosis and targeted treatment for mesothelioma patients.

READ MORE

Disease Detectives: Working on the Frontline

Article

Throughout human history, we have always been at war with infectious agents. In the past, there used to be less sophisticated tools to identify epidemics. Nowadays, more advanced technologies, such as genomic sequencing, are being harnessed to gain information about infectious agents.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Informatics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE